Pfizer's 2022 sales forecast disappoints investors
Pfizer's 2022 sales forecast disappoints investors
February 08, 2022
Shares of Pfizer fell after the drugmaker's forecast for this year's sales of its COVID-19 vaccine and antiviral pills came in below Wall Street estimates.
Post A Comment:
0 comments:
Leave a comment. Thanks!